1. Bastian, Lorenz, Hartmann, Alina M, Beder, Thomas, Brüggemann, Monika, Baldus, Claudia D. 2022. UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment. In Leukemia, 36, 1676-1680. doi:10.1038/s41375-022-01557-6. https://pubmed.ncbi.nlm.nih.gov/35397658/
2. Kimura, Shunsuke, Montefiori, Lindsey, Iacobucci, Ilaria, Blombery, Piers, Mullighan, Charles G. . Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia. In Blood, 139, 3519-3531. doi:10.1182/blood.2022015444. https://pubmed.ncbi.nlm.nih.gov/35192684/
3. Sun, Ning, Zhong, Xinping, Wang, Shengli, Wang, Chunyu, Zhao, Yue. 2020. ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function. In EBioMedicine, 62, 103108. doi:10.1016/j.ebiom.2020.103108. https://pubmed.ncbi.nlm.nih.gov/33186807/
4. Passet, Marie, Kim, Rathana, Gachet, Stéphanie, Boissel, Nicolas, Clappier, Emmanuelle. . Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL. In Blood, 139, 3505-3518. doi:10.1182/blood.2021014723. https://pubmed.ncbi.nlm.nih.gov/35316324/
5. Li, Wenqian, Atanassov, Boyko S, Lan, Xianjiang, Workman, Jerry L, Dent, Sharon Y R. 2016. Cytoplasmic ATXN7L3B Interferes with Nuclear Functions of the SAGA Deubiquitinase Module. In Molecular and cellular biology, 36, 2855-2866. doi:10.1128/MCB.00193-16. https://pubmed.ncbi.nlm.nih.gov/27601583/
6. Atanassov, Boyko S, Mohan, Ryan D, Lan, Xianjiang, Workman, Jerry L, Dent, Sharon Y R. 2016. ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth. In Molecular cell, 62, 558-71. doi:10.1016/j.molcel.2016.03.030. https://pubmed.ncbi.nlm.nih.gov/27132940/
智鼠故事 
